Business Description
Oncolytics Biotech Inc
NAICS : 325412
SIC : 3741
ISIN : CA6823108759
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 22.27 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 7.3 | |||||
3-Year EPS without NRI Growth Rate | 10.4 | |||||
3-Year FCF Growth Rate | 8.4 | |||||
3-Year Book Growth Rate | -11.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 9.93 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.71 | |||||
9-Day RSI | 74.64 | |||||
14-Day RSI | 72.06 | |||||
6-1 Month Momentum % | -17.42 | |||||
12-1 Month Momentum % | -54.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.99 | |||||
Quick Ratio | 4.99 | |||||
Cash Ratio | 4.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.3 | |||||
Shareholder Yield % | -21.18 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -116.67 | |||||
ROA % | -76.28 | |||||
ROIC % | -1044.92 | |||||
ROC (Joel Greenblatt) % | -2146.05 | |||||
ROCE % | -116.72 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 7.61 | |||||
Price-to-Tangible-Book | 7.54 | |||||
EV-to-EBIT | -3.16 | |||||
EV-to-Forward-EBIT | -3.17 | |||||
EV-to-EBITDA | -3.18 | |||||
EV-to-Forward-EBITDA | -1.03 | |||||
EV-to-Forward-Revenue | 25.14 | |||||
EV-to-FCF | -3.88 | |||||
Price-to-Net-Current-Asset-Value | 8.23 | |||||
Price-to-Net-Cash | 12.93 | |||||
Earnings Yield (Greenblatt) % | -31.66 | |||||
FCF Yield % | -20.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Oncolytics Biotech Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.38 | ||
Beta | 1.12 | ||
Volatility % | 28.42 | ||
14-Day RSI | 72.06 | ||
14-Day ATR (C$) | 0.130723 | ||
20-Day SMA (C$) | 1.345 | ||
12-1 Month Momentum % | -54.12 | ||
52-Week Range (C$) | 1.15 - 2.81 | ||
Shares Outstanding (Mil) | 76.86 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Oncolytics Biotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Oncolytics Biotech Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Oncolytics Biotech Inc Frequently Asked Questions
What is Oncolytics Biotech Inc(TSX:ONC)'s stock price today?
When is next earnings date of Oncolytics Biotech Inc(TSX:ONC)?
Does Oncolytics Biotech Inc(TSX:ONC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |